Risk Factors for Atrial Arrhythmias in Adults With Ebstein Anomaly.

Ebstein anomaly atrial arrhythmia atrial fibrillation atrial flutter left atrial volume index right atrial reservoir strain

Journal

JACC. Advances
ISSN: 2772-963X
Titre abrégé: JACC Adv
Pays: United States
ID NLM: 9918419284106676

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 24 03 2022
revised: 06 06 2022
accepted: 17 06 2022
medline: 26 8 2022
pubmed: 26 8 2022
entrez: 28 6 2024
Statut: epublish

Résumé

Atrial arrhythmias (AA) are common in Ebstein anomaly (EA), but risk factors associated with AA are not well understood. The purpose of this study was to determine the prevalence and risk factors for AA at baseline, incidence, and risk factors for AA during follow-up. Adults with EA receiving care at Mayo Clinic, MN, between 2003 and 2020 were included. AA was defined as atrial fibrillation (AF) or atrial flutter/tachycardia (AFL). Clinical, echocardiographic, rhythm, surgical data were collected. Of 682 patients (aged 36 [24-49] years), 235 (34%) had AA at baseline (126 [18%] AF and 144 [21%] AFL), and the risk factors for AA were age, left and right atrial volume indexes, and reservoir strain. Among 447 patients without AA, 10-year cumulative incidence of AF and AFL was 16% and 22%, respectively. The risk factors for incident AF were older age and right atrial reservoir strain. The risk factors for incident AFL were atrial septal defect, left atrial volume index, and male sex. Among patients with baseline AA, 129 (40%) had recurrent episodes (AF 63 [20%], AFL 78 [24%]). The 5-year recurrence rate of AA was 34%, without significant difference for AF vs AFL (46% vs 27%, Patients with EA are at risk for incident and recurrent AA. AF was almost as common as AFL despite relatively young ages. Echocardiographic indexes of atrial function can identify at-risk patients, hence be used to improve risk stratification and guide therapy.

Sections du résumé

Background UNASSIGNED
Atrial arrhythmias (AA) are common in Ebstein anomaly (EA), but risk factors associated with AA are not well understood.
Objectives UNASSIGNED
The purpose of this study was to determine the prevalence and risk factors for AA at baseline, incidence, and risk factors for AA during follow-up.
Methods UNASSIGNED
Adults with EA receiving care at Mayo Clinic, MN, between 2003 and 2020 were included. AA was defined as atrial fibrillation (AF) or atrial flutter/tachycardia (AFL). Clinical, echocardiographic, rhythm, surgical data were collected.
Results UNASSIGNED
Of 682 patients (aged 36 [24-49] years), 235 (34%) had AA at baseline (126 [18%] AF and 144 [21%] AFL), and the risk factors for AA were age, left and right atrial volume indexes, and reservoir strain. Among 447 patients without AA, 10-year cumulative incidence of AF and AFL was 16% and 22%, respectively. The risk factors for incident AF were older age and right atrial reservoir strain. The risk factors for incident AFL were atrial septal defect, left atrial volume index, and male sex. Among patients with baseline AA, 129 (40%) had recurrent episodes (AF 63 [20%], AFL 78 [24%]). The 5-year recurrence rate of AA was 34%, without significant difference for AF vs AFL (46% vs 27%,
Conclusions UNASSIGNED
Patients with EA are at risk for incident and recurrent AA. AF was almost as common as AFL despite relatively young ages. Echocardiographic indexes of atrial function can identify at-risk patients, hence be used to improve risk stratification and guide therapy.

Identifiants

pubmed: 38938391
doi: 10.1016/j.jacadv.2022.100058
pii: S2772-963X(22)00062-X
pmc: PMC11198643
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100058

Informations de copyright

© 2022 The Authors.

Déclaration de conflit d'intérêts

Dr Egbe is supported by National Heart, Lung, and Blood Institute (NHLBI) grants (R01 HL158517 and R01 160761). The MACHD Registry is supported by the Al-Bahar research grant. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Auteurs

Irene Martin de Miguel (I)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

William R Miranda (WR)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Malini Madhavan (M)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Heidi M Connolly (HM)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Joseph A Dearani (JA)

Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA.

Alexander C Egbe (AC)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

Classifications MeSH